Source: Annual Congress 2006 - Pulmonary hypertension: thromo-embolic processes



Rating:

Share or cite this content

Citations should be made in the following way:
G. C. H. Maglaras, L. S. Dova, G. G. Baxevanos, C. A. Katsanos, G. A. Vartholomatos, N. I. Kolaitis, Z. M. Metafratzi, S. H. Constantopoulos, M. P. Vassiliou (Ioannina, Greece). Acquired and inherited risk factors in cases of idiopathic and secondary pulmonary embolism in North-Western Greece. Eur Respir J 2006; 28: Suppl. 50, 2359

Member's Comments

No comment yet.

Related content which might interest you: Contribution of thrombophilic genetic factors in development and recurrent manifestation of pulmonary embolism in young patients Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005 Course of disease and cause of death in patients with idiopathic pulmonary fibrosis in Eastern Finland Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival Source: Eur Respir J 2013; 42: 1271-1282 Year: 2013 Prevalence of pulmonary hypertension in a large cohort of patients with hereditary hemorrhagic telangiectasia Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Abernethy syndrome: A rare cause of pulmonary hypertension Source: International Congress 2018 – Paediatric bronchology Year: 2018 Presence of inherited risk factors in patients with pulmonary thromboembolism (PTE) Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005 Pulmonary tuberculosis relapse: predisposing factors and management in Tunisia Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 Thrombophilic risk factors for chronic thromboembolic pulmonary hypertension (CTEPH) in Korea Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 The genetic risk factors for the recurrent pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 100s Year: 2005 Pulmonary hypertension in patients with lupus: Prevalence, etiology and risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries Year: 2012 Thrombophilia in patients with idiopathic pulmonary thromboembolism vs associated with risk factors Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Pulmonary embolism in China: disease burden, management and prevention Source: Virtual Congress 2020 – Chinese programme 2020: Part II Year: 2020 Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF) Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 Fatal pulmonary embolism in young people: risk factors and clinical presentation Source: Annual Congress 2009 - Intensive care unit management and outcome Year: 2009 Managing pulmonary hypertension in patients with congenital heart disease Source: Eur Respir Mon 2012; 57: 71-81 Year: 2012 Ortner‘s syndrome associated with secondary pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 55s Year: 2004 How to follow-up patients with hereditary haemorrhagic telangiectasia and suspected pulmonary arteriovenous malformations Source: Eur Respir J 2016; 47:1618-1621 Year: 2016 Chronic sinusitis may be one of the risk factors developing and deteriorating primary MAC pulmonary disease in Japan Source: Eur Respir J 2005; 26: Suppl. 49, 414s Year: 2005 Down syndrome and pulmonary hemosiderosis: an under-recognized association Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia Source: Eur Respir J 2004; 23: 373-377 Year: 2004